These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Approaches to the reversal of malnutrition, inflammation, and atherosclerosis in end-stage renal disease. Caglar K; Hakim RM; Ikizler TA Nutr Rev; 2002 Nov; 60(11):378-87. PubMed ID: 12462522 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology of vascular disease in renal failure. Ikizler TA Blood Purif; 2002; 20(1):6-10. PubMed ID: 11803153 [TBL] [Abstract][Full Text] [Related]
5. Myocardial microvascular disease and major adverse cardiovascular events in patients with end-stage renal disease: rationale and design of the MICROCARD study. Bejan-Angoulvant T; Bergerot C; Juillard L; Mezergues A; Morelon E; Pouteil-Noble C; André-Fouët X; Angoulvant D Nephrol Dial Transplant; 2012 Jul; 27(7):2886-91. PubMed ID: 22344775 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology of cardiovascular risk factors in chronic renal disease. Coresh J; Longenecker JC; Miller ER; Young HJ; Klag MJ J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S24-30. PubMed ID: 11443765 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular care in end-stage renal disease. McCullough PA Adv Chronic Kidney Dis; 2004 Jul; 11(3):245. PubMed ID: 15241738 [TBL] [Abstract][Full Text] [Related]
8. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253 [TBL] [Abstract][Full Text] [Related]
9. Screening and risk stratification of coronary artery disease in end-stage renal disease. Hakeem A; Bhatti S; Chang SM JACC Cardiovasc Imaging; 2014 Jul; 7(7):715-28. PubMed ID: 25034921 [TBL] [Abstract][Full Text] [Related]
10. [Chronic inflammation and cardiovascular risk in hemodialysis]. Pertosa G; Simone S; Soccio M; Marrone D; Grandaliano G G Ital Nefrol; 2003; 20(6):631-40. PubMed ID: 14732917 [TBL] [Abstract][Full Text] [Related]
11. [Why do patients with kidney diseases end up with a heart of stone? Disturbances in calcium-phosphate balance and chronic inflammation important causes]. Martola L; Elinder CG; Stenvinkel P Lakartidningen; 2003 Dec; 100(50):4180-3. PubMed ID: 14717005 [TBL] [Abstract][Full Text] [Related]
13. Opportunities for improvement in the cardiovascular care of patients with end-stage renal disease. McCullough PA Adv Chronic Kidney Dis; 2004 Jul; 11(3):294-303. PubMed ID: 15241743 [TBL] [Abstract][Full Text] [Related]
14. Role of nutrition for cardiovascular risk reduction in chronic kidney disease patients. Ikizler TA Adv Chronic Kidney Dis; 2004 Apr; 11(2):162-71. PubMed ID: 15216487 [TBL] [Abstract][Full Text] [Related]
16. Pathophysiologic and treatment strategies for cardiovascular disease in end-stage renal disease and kidney transplantations. Ghanta M; Kozicky M; Jim B Cardiol Rev; 2015; 23(3):109-18. PubMed ID: 25420053 [TBL] [Abstract][Full Text] [Related]
17. Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia? Nishizawa Y; Shoji T; Ishimura E; Inaba M; Morii H Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S4-7. PubMed ID: 11576913 [TBL] [Abstract][Full Text] [Related]
18. [Cardiac anomalies in chronic renal failure]. Guérin A; Marchais S; Pannier B; London G Presse Med; 2000 Feb; 29(5):274-80. PubMed ID: 10701411 [TBL] [Abstract][Full Text] [Related]
19. Undertreatment of cardiac risk factors in adolescents with renal failure. Querfeld U Perit Dial Int; 2001; 21 Suppl 3():S285-9. PubMed ID: 11887837 [TBL] [Abstract][Full Text] [Related]